US Markets Closed
AI-assisted · Not financial adviceNot adviceAI-assisted · Not financial advice.
Options positioning: Neutral — More betting on upside (1.2× more call than put volume today). Unusual bets on $440 downside — 6× normal activity. analysts: 21 buy vs 1 sell.
Retail concerns about liquidity overshadow growth potential in Lockheed Martin's medical tech. News of upgrades amid contract wins indicates potential for recovery.
Lockheed Martin Upgraded Amid Contract Wins
Target: $627 avg (+8% upside)
21 Buy · 15 Hold · 1 Sell
Based on curated news sources (not retail comments)
Over the last 7 days: Lockheed Martin's substantial new contracts and recent upgrade reflect strong growth prospects.